Cart
sales@molnova.com
MK-0686
CAS No. 1159193-97-1
MK-0686( —— )
Catalog No. M34653 CAS No. 1159193-97-1
MK-0686 is an orally available bradykinin B1 receptor antagonist with potential anti-inflammatory activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 290 | Get Quote |
|
| 5MG | 447 | Get Quote |
|
| 10MG | 655 | Get Quote |
|
| 25MG | 994 | Get Quote |
|
| 50MG | 1343 | Get Quote |
|
| 100MG | 1764 | Get Quote |
|
| 500MG | 3537 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMK-0686
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-0686 is an orally available bradykinin B1 receptor antagonist with potential anti-inflammatory activity.
-
DescriptionMK-0686 is an orally available bradykinin B1 receptor antagonist with potential anti-inflammatory activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetBradykinin Receptor
-
RecptorBradykinin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1159193-97-1
-
Formula Weight486.84
-
Molecular FormulaC22H19ClF4N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC(C)C1=C(F)C=C(C=C1)C2=C(C(OC)=O)C(Cl)=CC=C2)(=O)C3(NC(C(F)(F)F)=O)CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Bradykinin (2-9)
Bradykinin (2-9) is a metabolite of Bradykinin, cleaved by Aminopeptidase P. Bradykinin (2-9) is an amino-truncated Bradykinin peptide.
-
Bradykinin (1-5)
Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE).The bradykinin (BK) fragment (1-5) (RPPGF) is among the most stable of naturally occurring metabolites. Bradykinin (1-5) may be used as a marker for BK production in vivo.
-
[Phe8Ψ(CH-NH)-Arg9]-...
Selective bradykinin B2 receptor agonist that is resistant to carboxypeptidase cleavage. 5-fold more potent and exhibits a more prolonged duration of action than bradykinin in vivo.
